Stay updated on Pembrolizumab SubQ vs IV in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab SubQ vs IV in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab SubQ vs IV in Melanoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    A new revision v3.6.0 adds a note that the study is no longer looking for participants, and the previous revision v3.5.5 is removed from the history.
    Difference
    0.3%
    Check dated 2026-06-12T16:11:18.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    New revision v3.5.5 is added to the study history, replacing the previous revision v3.5.4. This indicates an update to the record's version rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-06-05T12:34:21.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    A new site revision entry (v3.5.4) was added and the previous revision (v3.5.3) removed in the record history, signaling a platform update to the ClinicalTrials.gov interface.
    Difference
    0.1%
    Check dated 2026-05-14T23:17:09.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The Record History page shows a new revision tag: v3.5.3 is now listed, replacing the previous v3.5.2, indicating a minor version update to the page’s history data.
    Difference
    0.1%
    Check dated 2026-04-30T17:31:45.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Revision: v3.5.2 replaces the previous version v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T11:11:36.000Z thumbnail image
  7. Check
    98 days ago
    Change Detected
    Summary
    Revision history updated with a new Revision v3.5.0 and removal of Revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T17:45:43.000Z thumbnail image

Stay in the know with updates to Pembrolizumab SubQ vs IV in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab SubQ vs IV in Melanoma Clinical Trial page.